H.R. 9171 is an appropriations bill that allocates funding for the Department of the Interior, the Environmental Protection Agency, and related agencies for the fiscal year 2027. The bill likely addresses budgetary needs for various programs related to natural resource management, environmental protection, and public lands administration.
Supporters of H.R. 9171 have praised the bill for its focus on environmental conservation and the protection of public lands. They highlight the importance of adequate funding for agencies that manage natural resources and address climate change, emphasizing that this investment is crucial for sustainable development and community resilience.
Critics of H.R. 9171 argue that the bill may not go far enough in addressing urgent environmental issues or may allocate funds to programs they view as ineffective. Some commentators express concern that the appropriations could lead to increased federal oversight and regulation, which they believe could hinder economic growth and local governance.
The analysis of H.R. 9171 reveals no direct industry overlaps between the sponsor, Michael Simpson's top donor industries and the bill's subject matter. While there is significant lobbying activity in the policy area, the contributions from these entities do not suggest a direct conflict of interest. For instance, the largest lobbying contribution comes from Grand Pharmaceutical Group Ltd, which contributed $90,000, but this does not directly correlate with the appropriations for the Department of the Interior or Environment. The other lobbying contributions, such as $20,000 from Prime Policy Group on behalf of New Hanover County and $18,000 from Torch Industries, also do not indicate a clear conflict with the bill's funding priorities. Voters should be aware that while lobbying exists, the absence of overlapping donor industries suggests a lower risk of conflicts in this instance.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| GRAND PHARMACEUTICAL GROUP LTD (FKA EAST OCEAN MEDICAL (HONG KONG) LIMITED) | CHECKMATE GOVERNMENT RELATIONS | $90,000 |
| PRIME POLICY GROUP ON BEHALF OF NEW HANOVER COUNTY, NC | KH STRATEGIES | $20,000 |
| YAKAMA NATION | MR. GEORGE WATERS | $20,000 |
| TORCH INDUSTRIES | 1836 ADVISORS | $18,000 |
| AMGEN INC. | WASHINGTON ADVOCACY GROUP | $5,000 |
| CITY AND COUNTY OF DENVER | CONVENTUM GROUP, LLC | undisclosed |
| FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED | MR. AMIR GOULART SCHARIF | undisclosed |
| FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED | MR. AMIR GOULART SCHARIF | undisclosed |
| BLACKSTONE CONSTRUCTION LLC | WASHINGTON ADVOCACY GROUP | undisclosed |
| DENALI WATER SOLUTIONS | WASHINGTON ADVOCACY GROUP | undisclosed |
| NATIONAL ASSOCIATION OF PROFESSIONAL EMPLOYER ORGANIZATIONS (NAPEO) | ARENTFOX SCHIFF LLP | undisclosed |
| RROMA COUNCIL | RROMA COUNCIL | undisclosed |
| BAJO COHEN AGLIANO, P.A. ON BEHALF OF HEALTH EDGE INVESTMENT PARTNERS, LLC | BALLARD PARTNERS | undisclosed |
| ERUDIO BIO, INC. | BALLARD PARTNERS | undisclosed |
| THE LOUIS D. BRANDEIS CENTER FOR HUMAN RIGHTS UNDER LAW | THE LOUIS D. BRANDEIS CENTER FOR HUMAN RIGHTS UNDER LAW | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Michael Simpson, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
